A “living drug” that could change the way we treat cancer
Carl June is a renowned pioneer in the fight against cancer. Carl June’s revolutionary leukemia therapy, which was recently approved by the FDA, uses genetically engineered versions of a patient’s own T cells and is the first personalized cell therapy for cancer to be sanctioned in America. Developed...